We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Study Reveals Mechanism Protecting UTI Bacteria from Nitric Acid Damage

By LabMedica International staff writers
Posted on 08 Nov 2016
Print article
Image: Cytochrome bd-I tagged with Green Fluorescent Protein can be visualized in the membrane of E. coli (Photo courtesy of Dr. Mark Shepherd, University of Kent).
Image: Cytochrome bd-I tagged with Green Fluorescent Protein can be visualized in the membrane of E. coli (Photo courtesy of Dr. Mark Shepherd, University of Kent).
A team of molecular microbiologists has identified the enzyme cytochrome bd-I oxidase as promoting urinary tract infections by being of critical importance in protecting E. coli bacteria from the effects of nitric oxide generated by the host's immune response.

Nitric oxide (NO) is a toxic free radical produced by neutrophils and macrophages in response to infection. Uropathogenic Escherichia coli (UPEC) generate a variety of defence mechanisms in response to NO, including direct NO detoxification, iron-sulphur cluster repair, and the expression of the NO-tolerant cytochrome bd-I respiratory oxidase.

Investigators at the University of Kent (United Kingdom) and colleagues at the University of Queensland (Brisbane, Australia) quantified the relative contribution of these systems to UPEC growth and survival during infection.

They reported in the October 21, 2016, online edition of the journal Scientific Reports that while UPEC have acquired a host of specialized mechanisms to evade NO-based stresses, the cytochrome bd-I respiratory oxidase was the main contributor to NO tolerance and host colonization under microaerobic conditions. Since cytochrome bd-I is absent in humans, drugs designed to target this enzyme would be less likely to be toxic to human cells.

Related Links:
University of Kent
University of Queensland

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.